Gabriel Ling - Nov 18, 2025 Form 4 Insider Report for Oncology Institute, Inc. (TOI)

Role
Director
Signature
/s/ Gabriel Ling
Stock symbol
TOI
Transactions as of
Nov 18, 2025
Transactions value $
$0
Form type
4
Date filed
11/20/2025, 04:02 PM
Previous filing
Nov 25, 2024
Next filing
Nov 24, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Ling Gabriel Director 18000 STUDEBAKER ROAD, SUITE 800, CERRITOS /s/ Gabriel Ling 2025-11-20 0001945281

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TOI Common Stock Other +141K +129.43% 250K Nov 18, 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of shares of common stock of the Issuer received by the reporting person through an in-kind distribution by M33 Growth I, L.P. to its limited partners and on a pro rata basis in accordance with their pecuniary interests therein in reliance on Rules 16a-9 and 16a-13 under the Securities Exchange Act of 1934, as amended.